IL314007A - Preparations for the treatment of baldness - Google Patents

Preparations for the treatment of baldness

Info

Publication number
IL314007A
IL314007A IL314007A IL31400724A IL314007A IL 314007 A IL314007 A IL 314007A IL 314007 A IL314007 A IL 314007A IL 31400724 A IL31400724 A IL 31400724A IL 314007 A IL314007 A IL 314007A
Authority
IL
Israel
Prior art keywords
compound
hair
pharmaceutically acceptable
acceptable salt
compounds
Prior art date
Application number
IL314007A
Other languages
English (en)
Hebrew (he)
Inventor
Lui SUN Daniel
Walter GIL Daniel
Original Assignee
Pelage Pharmaceuticals Inc
Lui SUN Daniel
Walter GIL Daniel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pelage Pharmaceuticals Inc, Lui SUN Daniel, Walter GIL Daniel filed Critical Pelage Pharmaceuticals Inc
Publication of IL314007A publication Critical patent/IL314007A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
IL314007A 2021-12-29 2022-12-21 Preparations for the treatment of baldness IL314007A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163294775P 2021-12-29 2021-12-29
PCT/US2022/082185 WO2023129854A1 (en) 2021-12-29 2022-12-21 Compounds for treatment of hair loss

Publications (1)

Publication Number Publication Date
IL314007A true IL314007A (en) 2024-08-01

Family

ID=85157456

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314007A IL314007A (en) 2021-12-29 2022-12-21 Preparations for the treatment of baldness

Country Status (12)

Country Link
US (1) US20250163045A1 (enExample)
EP (1) EP4457226A1 (enExample)
JP (1) JP2025502850A (enExample)
KR (1) KR20240129011A (enExample)
CN (1) CN118829641A (enExample)
AR (1) AR128100A1 (enExample)
AU (1) AU2022425460A1 (enExample)
CA (1) CA3244825A1 (enExample)
IL (1) IL314007A (enExample)
MX (1) MX2024008333A (enExample)
TW (1) TW202333692A (enExample)
WO (1) WO2023129854A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12649736B2 (en) 2019-12-20 2026-06-09 The Regents Of The University Of California Synthesis of compounds to promote hair growth
EP4172159A4 (en) 2020-06-30 2024-01-10 The Regents of the University of California Compositions and methods for modulating hair growth
CN121005682A (zh) * 2024-05-24 2025-11-25 上海医药工业研究院有限公司 一种2-苯基-吡咯类化合物、其制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL321754A (en) 2017-06-30 2025-08-01 Univ California Compositions and methods for modulating hair growth
MX2021008089A (es) * 2019-01-02 2021-08-05 Univ California Composiciones y metodos para modular el crecimiento del cabello.
EP4172159A4 (en) * 2020-06-30 2024-01-10 The Regents of the University of California Compositions and methods for modulating hair growth
EP4172158A4 (en) * 2020-06-30 2024-01-10 The Regents of the University of California Compositions and methods for modulating hair growth

Also Published As

Publication number Publication date
CN118829641A (zh) 2024-10-22
CA3244825A1 (en) 2023-07-06
WO2023129854A1 (en) 2023-07-06
AR128100A1 (es) 2024-03-27
TW202333692A (zh) 2023-09-01
MX2024008333A (es) 2024-08-30
KR20240129011A (ko) 2024-08-27
EP4457226A1 (en) 2024-11-06
US20250163045A1 (en) 2025-05-22
AU2022425460A1 (en) 2024-07-18
JP2025502850A (ja) 2025-01-28

Similar Documents

Publication Publication Date Title
WO2023129854A1 (en) Compounds for treatment of hair loss
IL314012A (en) Preparations for the treatment of baldness
AU2023201669B2 (en) Compositions and methods for modulating hair growth
CA2880275C (en) Pharmaceutical or cosmetic composition for treating alopecia
EP0420707B1 (fr) Compositions destinées à être utilisées pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des dérivés de l'amino-2 pyrimidine oxyde-3 et nouveaux composés dérivés de l'amino-2 pyrimidine oxyde-3
EP0459890B1 (fr) Composition destinée à être utilisée pour freiner la chute des cheveux et pour induire et stimuler leur croissance,contenant des dérivés d'alkyl-2 amino-4 (ou dialkyl-2,4) pyrimidine oxyde-3 et nouveaux composés dérivés d'alkyl-2 amino-4 pyrimidine oxyde-3
KR20210110817A (ko) 모발 성장을 조절하기 위한 조성물 및 방법
EP1807412A1 (en) Cyclic diarly ureas suitable as tyrosine kinase inhibitors
WO2022006039A1 (en) Compositions and methods for modulating hair growth
EP4642783A1 (en) Compounds for treatment of hair loss
CN103826638A (zh) 含有pde5抑制剂的减少皮肤皱纹的组合物
HK40118300A (en) Compounds for treatment of hair loss
US6271244B1 (en) N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
CA1332569C (en) Topical preparation
AU764073B2 (en) N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
AU7807998A (en) N-linked sulfonamide of heterocyclic thioester hair growth compounds and uses
WO1999062485A1 (en) N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
TH50589B (th) 3,3-ไดแอริลโพรพิลามีน, การใช้ และการเตรียมของมัน
TH50176A (th) 3,3-ไดแอริลโพรพิลามีน, การใช้ และการเตรียมของมัน
MXPA00011877A (es) Composiciones y usos de molecula pequeña de carbamato o urea para el crecimiento del pelo